Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 117.65 USD -0.8%
Market Cap: 204.7B USD
Have any thoughts about
Abbott Laboratories?
Write Note

Abbott Laboratories
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbott Laboratories
Revenue Peer Comparison

Comparables:
BDX
BSX
EW
SYK
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Abbott Laboratories
NYSE:ABT
Revenue
$41.2B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.8B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$15.9B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
8%
Edwards Lifesciences Corp
NYSE:EW
Revenue
$5.6B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Revenue
$22B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.9B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
14%

Abbott Laboratories
Revenue Breakdown

Breakdown by Geography
Abbott Laboratories

Total Revenue: 40.1B USD
100%
International: 24.7B USD
61.5%
United States: 15.5B USD
38.5%
All Other Countries: 14.1B USD
35.1%
Germany: 2.3B USD
5.8%
China: 2.3B USD
5.6%
India: 1.8B USD
4.4%
Switzerland: 1.6B USD
4.1%
Japan: 1.5B USD
3.8%
Netherlands: 1.1B USD
2.7%
Show More
Show Less

Breakdown by Segments
Abbott Laboratories

Total Revenue: 40.1B USD
100%
Medical Devices: 16.9B USD
42.1%
Diagnostic Products: 10B USD
24.9%
Nutritional Products: 8.2B USD
20.3%
Established Pharmaceutical Products: 5.1B USD
12.6%
Show More
Show Less

See Also

What is Abbott Laboratories's Revenue?
Revenue
41.2B USD

Based on the financial report for Sep 30, 2024, Abbott Laboratories's Revenue amounts to 41.2B USD.

What is Abbott Laboratories's Revenue growth rate?
Revenue CAGR 10Y
8%

Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for Abbott Laboratories have been -1% over the past three years , 6% over the past five years , and 8% over the past ten years .

Back to Top